Unichem Laboratories Limited has received ANDA approval from the US Food and Drug Administration (FDA) for asthma drug, montelukast sodium tablet.
Montelukast sodium tablets 10 mg are therapeutically equivalent to Singulair tablets 10 mg of Merck Sharp & Dohme Corp.
Montelukast is a leukotriene receptor antagonist (LTRA) which is indicated for prophylaxis and chronic treatment of asthma in adults and adolescents patients. It is also used to prevent exercise-induced bronchoconstruction and to provide relief from symptoms of allergic rhinities in adults and adolescents patients.
The product will be commercialised from Unichem's Goa plant.
The company now has total of 19 ANDA approvals (including 3 tentative approvals) from US FDA.
Montelukast sodium tablets 10 mg are therapeutically equivalent to Singulair tablets 10 mg of Merck Sharp & Dohme Corp.
Montelukast is a leukotriene receptor antagonist (LTRA) which is indicated for prophylaxis and chronic treatment of asthma in adults and adolescents patients. It is also used to prevent exercise-induced bronchoconstruction and to provide relief from symptoms of allergic rhinities in adults and adolescents patients.
Also Read
The product will be commercialised from Unichem's Goa plant.
The company now has total of 19 ANDA approvals (including 3 tentative approvals) from US FDA.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%